Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology leverages molecular simulations to examine a vast array of proteins, capturing their dynamics in both isolated forms and in complexes with other proteins. Through ensemble virtual screening, we thoroughly account for the protein's conformational mobility, identifying critical binding sites within functional regions and distant allosteric locations. This detailed exploration ensures that we comprehensively assess every possible mechanism of action, with the objective of identifying novel therapeutic targets and lead compounds that span a wide spectrum of biological functions.
Our library stands out due to several important features:
partner
Reaxense
upacc
O00482
UPID:
NR5A2_HUMAN
Alternative names:
Alpha-1-fetoprotein transcription factor; B1-binding factor; CYP7A promoter-binding factor; Hepatocytic transcription factor; Liver receptor homolog 1
Alternative UPACC:
O00482; B4E2P3; O95642; Q147U3
Background:
Nuclear receptor subfamily 5 group A member 2, known as Liver receptor homolog 1 among other names, plays a pivotal role in lipid metabolism, cholesterol homeostasis, and triglyceride synthesis. It acts as a metabolic sensor, regulating genes essential for bile acid synthesis and cholesterol 7-alpha-hydroxylase gene expression in the liver. Additionally, it serves an anti-inflammatory role by inhibiting the hepatic acute phase response, showcasing its importance in liver function and development.
Therapeutic significance:
Understanding the role of Nuclear receptor subfamily 5 group A member 2 could open doors to potential therapeutic strategies. Its critical function in regulating lipid metabolism and anti-inflammatory responses highlights its potential as a target for treating metabolic disorders and inflammatory conditions.